Actively Recruiting

Phase Not Applicable
Age: 18Years - 70Years
All Genders
NCT07163975

Complete Pulpotomy and Root Canal Treatment Patients With Irreversible Pulpitis With Type 2 Diabetes Mellitus

Led by Postgraduate Institute of Dental Sciences Rohtak · Updated on 2025-09-09

106

Participants Needed

1

Research Sites

104 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

there is limited endodontic research on the effects of DM on pulp tissues. Diabetic human and animal histological research have demonstrated decreased wound repair, chronic pulp inflammation and reduced dentin bridge formation. To date, no human clinical trial has examined the impact of diabetes mellitus on teeth with irreversible pulpitis. Due to the paucity of data in the literature, there is a clinical dilemma whether to recommend root canal therapy or vital pulp therapy in diabetic patients with irreversible pulpitis. To the best of our knowledge, no prospective study has evaluated the outcome of complete pulpotomy versus root canal treatment in T2DM patients with irreversible pulpitis. The aim of this study is to compare and evaluate the success rates of pulpotomy and root canal treatment in type 2 diabetes mellitus patients in mature permanent teeth presenting with clinical symptoms of irreversible pulpitis.

CONDITIONS

Official Title

Complete Pulpotomy and Root Canal Treatment Patients With Irreversible Pulpitis With Type 2 Diabetes Mellitus

Who Can Participate

Age: 18Years - 70Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Diagnosed with type 2 diabetes mellitus (HbA1c 6.5%-8%, FPG ≥126 mg/dL, 2-hour plasma glucose ≥200 mg/dL during OGTT, or random plasma glucose ≥200 mg/dL with hyperglycemia symptoms)
  • Age between 18 and 70 years
  • Have permanent mandibular posterior teeth with clinical and radiographic signs of irreversible pulpitis (PAI score ≤2)
  • Tooth shows positive response to pulp sensibility testing and no tenderness on percussion
  • Body mass index (BMI) less than 30 Kg/m2
Not Eligible

You will not qualify if you...

  • Have immunocompromised diseases or chronic kidney disease
  • Are smokers, pregnant, or lactating women
  • Teeth with immature roots or retained deciduous teeth
  • Bleeding that cannot be controlled within 5 minutes
  • Tooth with signs or symptoms of apical periodontitis
  • Teeth with procedural errors, cracks, or fractures
  • Tooth with probing depth greater than 4 mm
  • Recent antibiotic use within 1 month or analgesic use within past 3 days
  • Taking drugs affecting bone metabolism such as immune-suppressants, SSRIs, bisphosphonates, or hormone replacement therapy

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

PGIDS Rohtak

Rohtak, Haryana, India, 124001

Actively Recruiting

Loading map...

Research Team

J

Jigyasa Duhan, MDS

CONTACT

A

Anmol Jain

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here